Altered molecular pathways in gliomas: an overview of clinically relevant issues.

Rao, Ravi D; James, C David

Rao, Ravi D; James, C David.

Affiliation

Rao RD; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Semin Oncol ; 31(5): 595-604, 2004 Oct.

Article in En | MEDLINE | ID: mdl-15497113

Subject(s)

Central Nervous System Neoplasms/genetics; Glioma/genetics; Animals; Antineoplastic Agents/pharmacology; Astrocytoma/diagnosis; Astrocytoma/drug therapy; Astrocytoma/genetics; Astrocytoma/metabolism; Central Nervous System Neoplasms/diagnosis; Central Nervous System Neoplasms/drug therapy; Central Nervous System Neoplasms/metabolism; Drug Delivery Systems; ErbB Receptors; Genes, p53; Genes, ras; Glioma/diagnosis; Glioma/drug therapy; Glioma/metabolism; Humans; Neovascularization, Pathologic; Oligodendroglioma/diagnosis; Oligodendroglioma/drug therapy; Oligodendroglioma/genetics; Oligodendroglioma/metabolism; Phosphatidylinositol 3-Kinases; Prognosis; Receptors, Platelet-Derived Growth Factor

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Neoplasms / Glioma Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Semin Oncol Year: 2004 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links